Insys Therapeutics (INSY) Hikes on FDA Nod

Insys Therapeutics Inc INSY shares rose 8.6% to $14.64 after the company reported that the FDA has approved the company's dronabinol oral solution, SyndrosTM. Share volume was 5.3 million, compared to an all-day average of 661,000